Bookmark
Forward
Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer.
Song Ding, Xin Qiao, Gregory L Kucera, Ulrich Bierbach
Chemical communications (Cambridge, England) 2013 Mar 25
Sizes of these terms reflect their relevance to your search.
The synthesis of a novel pharmacophore comprising a DNA-targeted platinum-acridine hybrid agent and estrogen receptor-targeted 4-hydroxy-N-desmethyltamoxifen (endoxifen) using carbamate coupling chemistry and its evaluation in breast cancer cell lines are described.
Citation
Song Ding, Xin Qiao, Gregory L Kucera, Ulrich Bierbach.
Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer.
Chemical communications (Cambridge, England).
2013 Mar 25;49(24):2415-7
Mesh Tags
Acridines
Antineoplastic Agents, Hormonal
Breast Neoplasms
Cell Line, Tumor
Cell Survival
DNA
Drug Design
Female
Humans
Intercalating Agents
MCF-7 Cells
Platinum
Receptors, Estrogen
Tamoxifen
Substances
Acridines
Antineoplastic Agents, Hormonal
Intercalating Agents
Receptors, Estrogen
Tamoxifen
4-hydroxy-N-desmethyltamoxifen
Platinum
DNA
PMID: 23416453
View Full Text